Korean J Pain.  2007 Jun;20(1):8-14. 10.3344/kjp.2007.20.1.8.

The Combined Antiallodynic Effect of Gabapentin and Milnacipran in a Rat Neuropathic Pain Model

Affiliations
  • 1Department of Anesthesia and Pain Medicine, Pusan National University, Busan, Korea. shinsw@pusan.ac.kr

Abstract

BACKGROUND: Anticonvulsants and antidepressants are adjuvant analgesic drugs that are used widely for treating chronic neuropathic pain syndromes. The combined analgesic effect of gabapentin and milnacipran was investigated with a rat neuropathic pain model.
METHODS
The rat neuropathic pain model was made by ligating the spinal nerves (L5 and L6). An intrathecal catheter was inserted into the subarachnoid space. Tactile allodynia was tested with the up-down method using von Frey hair. We determined the antiallodynic effect of intraperitoneal (I.P.) and intrathecal (I.T.) gabapentin. The combined effect of I.P. gabapentin (50 mg/kg) and milnacipran (0, 10 and 30 mg/kg) was investigated.
RESULTS
Intraperitoneal and intrathecal administration of gabapentin increased the threshold for tactile allodynia (the ED50 was 60.6 mg/kg and 45.5microng, respectively). Co-administration of I.P. milnacipran increased the antiallodynic effect of I.P. gabapentin in a dose-dependent fashion.
CONCLUSION
The combined administration of milnacipran and gabapentin may increase the total analgesic effect during treatment of neuropathic pain.

Keyword

analgesia; gabapentin; milnacipran; neuropathic pain
Full Text Links
  • KJP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2021 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr